Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
Date:10/24/2007

r actual results to differ materially are the following: our ability to successfully complete cost-effective clinical trials for the drug candidates in our pipelines, including Sulonex, Zerenex and KRX-0401; we may not be able to meet anticipated development timelines for Sulonex, Zerenex or KRX-0401 due to recruitment, clinical trial results, manufacturing capabilities or other factors; and other risk factors identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at http://www.keryx.com. The information in our website is not incorporated by reference into this press release and is included as an inactive textual reference only.

KERYX CONTACT:

Lauren Fischer

Director - Investor Relations

Keryx Biopharmaceuticals, Inc.

Tel: 212.531.5965

E-mail: lfischer@keryx.com

Selected Consolidated Financial Data

(Thousands of Dollars, Except Share and Per Share Data)

Statements of Operations Information:

Three Months Ended Nine Months Ended

September 30, September 30,

(unaudited) (unaudited)

2007 2006 2007 2006

REVENUE:

License revenue $ 41 $ -- $ 41 $ --

Diagnostic revenue -- 35 66 58

Service revenue 11 39 37 375

TOTAL REVENUE
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), ... today announced that it will be launching the ... gene-expression profiling using its SmartChip(TM) Real-Time PCR System. ... comprehensive human microRNA panel of 885 microRNAs on ... offers customers the use of its proprietary SmartChip ...
(Date:12/16/2009)... Resources, one of the world,s leading research and ... that, according to responses from surveyed dermatologists, Centocor ... inhibitors) will capture 22 percent of the biologics ... moderate to severe psoriasis. Among these two agents, ... times as much patient share as briakinumab. ...
(Date:12/16/2009)... December 16 Eppendorf has initiated ... Verigene(R) SP systems for,infringement of European patent ... for the,identification and/or the quantification of a ... all imports of the respective products into ... are required to confiscate any,violating products. , ...
(Date:12/15/2009)... WALTHAM, Mass., Dec. 15 Repligen Corporation ... Company has received $731,000 in research funding to ... Friedreich,s ataxia from the Muscular Dystrophy Association (MDA). ... preclinical GLP toxicology testing and GMP manufacture of ... Support from the MDA not only provides important ...
Breaking Biology Technology:WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 4In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3
... Public on Dangers of UV Rays to Vision, CHICAGO, ... may want to head to their local tanning salon to ... and shorts. But without the proper,protection, tanning beds can cause ... According to the American Academy of Dermatology, more than 1,million ...
... 30 MedThink Communications, an,innovator in medical ... hired two executives to serve the company,s ... industry., Steven Palmisano, the new vice ... services team as it integrates creative thinking,and ...
... Shandong, China, April 30 /Xinhua-PRNewswire-FirstCall/ --,China Biologic ... or "the,Company"), one of the leading plasma-based ... ("PRC"), today announced that the Company,received approval ... Administration,("SFDA") (1) to start the production of ...
Other Biology Technology:Tanning and Excessive Sun Exposure Can Cause Severe Damage to Eyes 2Tanning and Excessive Sun Exposure Can Cause Severe Damage to Eyes 3MedThink Hires Two Executives to Serve its Growing Pharmaceutical Client Base 2China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex 2China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex 3
(Date:12/15/2009)... 2009 Frost & Sullivan European Border Security ... Securite (Safran Group) for its innovative Automated ... company,s expertise in advanced biometric technology and ... products to end users. ,, (Logo: ... has been involved in delivering identification systems ...
(Date:12/15/2009)... Biotech, Inc. GenWay Clinical Laboratory, San Diego, California, ... of American Pathologists (CAP), based on results of ... laboratory,s director was advised of this national recognition ... being provided." GenWay Biotech Inc. GenWay Clinical Laboratory ... , The CAP Laboratory Accreditation Program, begun in ...
(Date:12/15/2009)... . , Leipzig: Species distribution models are of only ... This is the finding of a study of the ... analysed data on species distribution, climate, land cover and ... species. Judging by the large differences in climate niches ... fast to changing climatic conditions. This in turn makes ...
Breaking Biology News(10 mins):Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4Species distribution models are of only limited value for predicting future mammal distributions 2Chiltern Expands European Operations With a New Office in Belgium 49279 1Chiltern Expands European Operations With a New Office in Belgium 49279 2GBS CIDP Foundation International Appoints Patricia A Bryant as Executive Director 49276 1GBS CIDP Foundation International Appoints Patricia A Bryant as Executive Director 49276 2Study supports validity of test that indicates widespread unconscious bias 49273 1Study supports validity of test that indicates widespread unconscious bias 49273 2
... barriers can halt the might of a tsunami are false ... , There are many reasons for preserving the world,s dwindling ... one of them, they say. , On the ... Tsunami, which claimed nearly a quarter of a million lives ...
... have what they think may be a basic recipe ... embryonic stem cells from essentially any mammal, including cows, ... the December 26th issue of the journal Cell ... first demonstrated to work in mice earlier this year, ...
... two enzymes that, when combined, could be involved in ... might lead to targeted therapies aimed at slowing or ... reactivate a completely normal gene in a tumor cell ... a tumor if reactivated," says David Jones, Ph.D., professor ...
Other Biology News:Trees won't stop tsunamis, scientists warn 2Trees won't stop tsunamis, scientists warn 3Recipe for capturing authentic embryonic stem cells may apply to any mammal, study suggests 2Recipe for capturing authentic embryonic stem cells may apply to any mammal, study suggests 3Newly found enzymes may play early role in cancer 2
Immunogen: Synthetic peptide: S(399) P W S E L E F Q F P D D K D P V W E F(418) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Vector NTI Advance 9.1 ... and highly integrated application ... and molecular biology data ... readily available for export. ...
...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
Biology Products: